An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings, now published in Angewandte Chemie International Edition, introduce a compound with strong activity against highly resistant bacterial strains.
Antibiotic-resistant infections are on the rise, threatening to make even common diseases deadly again. Without new antibiotics,…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply